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Shiga toxin-producing Escherichia coli are pathogenic bacteria found in the gastrointestinal 
tract of humans. Severe infections could lead to life threatening complications especially in 
young children and the elderly. Understanding the distribution of the incubation period, 
which is currently inconsistent and ambiguous, can help in controlling the burden of disease.  
We have undertaken a systematic review of outbreak investigation reports, extracted 
individual incubation data and summary estimates, tested for heterogeneity, classified studies 
into subgroups with limited heterogeneity and undertook a meta-analysis to identify factors 
that may contribute to the distribution of incubation period.  
Twenty-nine studies were identified for inclusion in the review, and the resulting value of I2 
was 77% indicating high heterogeneity. Studies were classified into five subgroups with the 
mean incubation period ranging from 3.5 to 8.1 days. The length of the incubation period 
increased with age and decreased by 7.2 hours with every 10% increase in attack rate.  
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STEC - Shiga-Toxigenic Escherichia coli 
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Shiga toxin-producing Escherichia coli (STEC) is a pathogenic form of the Escherichia coli 
(E. coli) bacteria. It is common and benign in many organisms, but usually causes illness in 
humans (1). Symptoms generally include severe stomach cramps, profuse diarrhoea which is 
often bloody, and vomiting (2). Symptoms could last between five to seven days (3), however 
severe infections can be life threatening and result in complications (2). A common 
complication of STEC infection is hemolytic uremic syndrome (HUS) which affects five to 
ten per cent of ill persons (1,3). 
There are several disease-causing STEC serogroups, but the most common is STEC O157 
(4),(5). Its reservoir is mainly cattle (6) and it is transmitted to humans through consumption 
of contaminated foods, fecal-oral transmission or cross contamination (5). Other STEC 
serotypes are collectively called non-O157 STEC. Numerous non-O157 strains have been 
identified however the most common serogroups associated with disease include O111, O26, 
O45, O103, and O145 (7,8).  
Globally, STEC is estimated to cause nearly 3 million cases annually leading to 
approximately 200 deaths (9). Most reported cases of STEC O157 are sporadic (10), but due 
to the low infectious dose required for infection to occur (10), there is the potential for large 
outbreaks (11). Cases of non-O157 are relatively fewer and likewise, non-O157 related 
outbreaks are rare, however, large outbreaks have also been reported (12). 
Incubation period is the time between exposure to the infecting pathogen and onset of clinical 
symptoms. Accurate knowledge of the distribution of incubation period is necessary for 
understanding its epidemiology, and is useful in outbreak investigations and distinguishing 
between primary and secondary cases which is an important factor in STEC epidemiology as 

























exposure is unknown, accurate knowledge of the incubation period distribution can help 
identify the potential source of contamination. 
There are several conflicting reports on the incubation period distribution of STEC. The 
World Health Organization reports a range of three to eight days (1), the Centre for Disease 
Prevention and Control report three to four days after exposure (3) and cases in a few notable 
outbreaks have reported unexpectedly long incubation period (13,14). Due to the ambiguity 
around the incubation period distribution of STEC, researchers have used other methods to 
identify the time of exposure in outbreak investigations (15).  
In order to describe the incubation period distribution of STEC, examine the ambiguity 
around the reported incubation period and identify possible influencing factors, the authors 
undertook a systematic review of published and grey literature reporting the incubation 
period of STEC in exposed populations. We extracted reported individual patient incubation 
data and summary estimates and undertook a meta-analysis and meta-regression of the 
extracted data. We tested for the presence of heterogeneity and attempted to explain observed 


























We undertook a systematic literature review of observational studies with known point 
sources in order to extract data on incubation period. These data were assessed for the 
presence of heterogeneity and subgroups with limited evidence of heterogeneity between 
them were identified. We conducted a meta-regression to identify factors that influence the 
incubation period distribution. Fuller details on methods used have already been published 
(16).  
 
Research questions and modified PICO elements 
Our research questions were: 
1. What is the distribution of the incubation period of STEC infections in humans? 
2. What factors affect the incubation period? 
The modified PICO elements and associated components are listed in Table 1.  
 
Search strategy 
A systematic literature search for peer reviewed publications and grey literature reports of 
observational and experimental studies reporting incubation period was conducted in 
bibliographic databases (PubMed and Scopus) and Google Scholar. A customised grey 
literature search of the websites: www.cdc.gov, www.who.int, www.opengrey.eu and open 
Google search (screening only the first fifty items) was undertaken using combinations of 
search terms (Web Table 1). All searches were carried out from 5 June 2017 to 3 July 2017. 
There was no restriction on the dates or language of articles returned. The reference lists of 
identified review papers were also screened to find other relevant studies where incubation 



























Following the identification of likely relevant articles from the literature review, each article 
went through a selection process and quality assessment. The steps involved in the selection 
process and quality assessment process have previously been described in Awofisayo-
Okuyelu et al (16).  
 
Data extraction 
Data were extracted from all included studies according to a pre-determined proforma (Web 
Table 2). When available, individual incubation period data were extracted from text and 
tables. Where an epidemic curve was provided, the raw incubation period data were extracted 
using the online tool, WebPlotDigitizer (17). Summary data, such as the mean, median and 
mode, were also extracted or calculated from the raw data where necessary. Raw data were 
used in the test for heterogeneity and the subgroup analysis. The summary data were used in 
the meta-regression analysis as explanatory variables were only available for outbreaks and 
not individuals. The unit of incubation data reported and extracted was days. For point source 
outbreaks, or outbreaks with continuous exposures where the total number of people exposed 
was observed and reported, the attack rate was determined.  
 
Descriptive analyses 
The extracted data were summarized according to the reported characteristics. Frequencies 
and percentages were calculated for year of study, study design, geographical region of study, 
serotype, toxin type, mode of transmission and food vehicle, where applicable.  
The extracted individual incubation period data were used to plot histograms of the 

























were plotted on a uniform x-axis representing the incubation period from one to twenty days 
and an individual y-axis indicating the number of cases in each outbreak.  
 
Statistical analyses 
We tested for the presence of heterogeneity using the individual incubation data, and the 
pattern of heterogeneity was investigated. We also identified factors that may explain 
heterogeneity using the summary statistics and available outbreak characteristics. Statistical 
analyses were done using the statistical software R version 3.2.3 (2015-12-10) – “Wooden 
Christmas Tree” (18).    
 
Testing for heterogeneity. Using the available individual data extracted from the studies, the 
test for heterogeneity was done by calculating the value of I2 and performing a two-sample 
Kolmogorov Smirnov test (KS test) to compare the cumulative distributions between studies. 
We applied a bootstrapped version of the test with 10,000 samples to derive p-values that will 
provide improved coverage given the compared data are discretized at the point of reporting 
(16).  
 
Identifying factors that explain heterogeneity. In order to examine the relationship between 
the outbreak characteristics and the mean incubation period, we performed a linear regression 
analysis. We fitted a generalized linear model, with a gamma family function and a link 
identity, to account for the skewness of data. The mean incubation period was the dependent 
variable and the outbreak or host characteristics were the explanatory variables. The 
association of the explanatory variables on the mean incubation period was examined first 
using a univariate model, and then by building a multivariable model with variables that had 


























Identifying subgroups. Following the confirmation of heterogeneity, we explored the data 
according to subgroups. Using the p-values of the bootstrapped KS test, we conducted a 
hierarchical cluster analysis to produce a graphical representation of the dissimilarity matrix 
between the studies (16).  
 
Subgroup analyses 
The individual incubation data of studies in a subgroup was collated and summary statistics 
and outcome measures were derived for each subgroup. A forest plot was created to show the 
distribution of the mean incubation period and the corresponding 95% confidence interval for 
studies with individual incubation data.  
 
Risk of bias 
Our data were tested for ‘small-study effect’ by creating a funnel plot which graphically 




























Search strategy and selection process 
A total of 1,980 unique articles were retrieved from both bibliographic databases, 840 from 
Google Scholar and 1,279 articles were identified from the grey literature search. After 
screening for relevance and removing duplicates identified from all three sources, 2,059 
articles were excluded (Figure 1). An additional 26 articles were identified from searching 
through reference list of relevant review papers resulting in 2066 articles for further 
screening. Excluding articles that did not report incubation period resulted in 42 articles for 
full text review and eligibility screening. A further fourteen articles were excluded as they did 
not meet the eligibility criteria (Web Table 3) resulting in 28 articles for inclusion and data 
extraction, one of which reported two outbreaks (Web Table 4). All of the included studies 
were outbreak reports, and 22 of these reported individual incubation period data available 
for extraction. Some outbreaks were part of larger outbreaks. Three outbreaks (19–21) within 
the German O104 outbreak, for which incubation time could be extracted, are included. It 
was not possible to include all cases in the 2011 German outbreak as incubation time was not 
known due to uncertain date of exposure. 
 
Descriptive analyses 
Of the 29 studies included in our review, 75.9% (22/29) were of serotype O157. All but one 
of the studies reported the onset of either bloody diarrhoea or HUS. Nine outbreaks (31%) 
each reported bloody diarrhoea alone or HUS alone and ten outbreaks (34.5%) reported both 
HUS and bloody diarrhoea (Table 2).  
Outbreaks involving mostly children account for about half (51.7%; 15/29) of the included 

























children reported settings such as farm visits (5/15), schools (4/15), and outdoor settings 
(4/15) such as swimming pools, camping and exposure to surface water. Outbreaks involving 
mostly adults reported settings such as private parties (6/13) and nursing homes (4/13).  
Foodborne transmission accounted for 69% (20/29) of the outbreaks of which 40% (8/20) 
were private parties, and 20% (4/20) took place in either a nursing home or a school. Non-
foodborne transmission accounted for 31% (9/29) of outbreaks, of which 44% (4/9) were 
associated with farm visits. The most commonly identified food categories in foodborne 
outbreaks were vegetables (35%; 7/20) and red meat (20%; 4/20) (Table 2).   
The funnel plot showed no evidence of small-study effect. It was a symmetrical funnel with 
small sample studies reporting both short and long incubation periods (Figure 2). The re-
created epidemic curves from the extracted individual data showed variation in the 
distribution of the incubation period (Web Figure 1).  
 
Test for heterogeneity 
The results of the Cochran’s Q statistics (<0.001) and I2 (77%) indicated high heterogeneity 
between the studies. From the KS test, 56% (143/253) of the resulting p-values were less than 
0.05 and the probability of obtaining this proportion by chance was <0.0001.  
 
Factors that may explain heterogeneity 
The results of the regression analysis showed outbreaks involving mostly children and attack 
rate as factors that may influence the mean incubation period. From the univariate analysis, 
outbreaks with children reported an incubation period of 2.7 days shorter than outbreaks 
involving adults (p-value – 0.01). A 10% rise in the attack rate resulted in a reduction in 

























analysis; however, the p-value indicated a borderline significant association with the mean 
incubation period (p-value- 0.06 for both) (Table 3).   
 
Identifying subgroups of studies 
The output of the clustering analysis produces a dendrogram visualizing the dissimilarity 
matrix. As a result of the pragmatic adjustment made to the significance level, the corrected 
p-value was 0.002, and subtracting this from 1 resulted in a cut-off point of 0.998. Applying 
this cut-off point to the dendrogram resulted in five subgroups of studies with limited 
evidence of heterogeneity between them. These consisted of a subgroup of seven studies, a 
subgroup with five studies, a subgroup of four studies and two subgroups with three studies 
each (Web Figure 2).  
 
Summary of subgroup analysis 
The mean incubation period between subgroups varied from 3.5 to 8.1 days, and differed 
significantly between subgroups 1 to 4 (Web Figure 3). Subgroups 2 and 4 had significantly 
longer mean incubation periods of 6.7 days and 8.1 days respectively compared with the 
other subgroups (Web Table 5). The variance, skew and kurtosis also differed, and were 
larger for subgroups with smaller sample sizes. Some variation was observed within 
subgroups particularly in outbreaks reporting symptoms of bloody diarrhoea and HUS and 
the outbreak setting.  
Two out of three outbreaks in subgroup 2 involved mostly adults and all outbreaks in 
subgroup 4 involved mostly adults. The distribution of serotypes in the subgroups was 
diverse, although all outbreaks involving serotype O104 were clustered within subgroup 4. 
Severity of symptoms was similar across subgroups as outbreaks in all subgroups reported 


























We have undertaken a systematic review of published and grey literature and identified 
articles reporting precisely estimated data on the incubation period of STEC. We extracted 
the reported data and due to the presence of heterogeneity, classified studies into five 
subgroups for analysis among which the mean incubation time varies as well as other 
measures of distribution such as the median and variance. The mean incubation period of the 
subgroups ranged from 3.5 to 8.1 days. Age and attack rate were identified as factors that 
influence incubation period.  
In our study, the length of incubation period increased with age as outbreaks involving 
mostly children reported shorter incubation periods. This contrasts with the findings of 
Werber et al (22) where incubation period decreased with age in a single O104 outbreak 
using individual patient data. Children are more at risk of STEC infections (9) for a number 
of reasons, some of which could also influence the incubation period. However, our study 
could only perform ecological analysis due to the lack of individual patient data and 
additionally lacked information to assess many possible explanatory factors that may explain 
the association of age with the distribution of incubation period.  
The attack rate of a disease and incubation period have been reported to have an inversely 
proportional relationship such that a higher attack rate results in a shorter incubation period in 
a study of Salmonella outbreaks (23). Our study showed that for every ten percent increase in 
attack rate, the incubation period was shortened by 7.2 hours or 0.3 days. Factors such as 
virulence of the pathogen, the infectious dose and host susceptibility which alter the attack 
rate of a disease in a population (24–27) and also the incubation period of the disease (28) 
may have contributed to this association.  
We did not find statistical evidence for association of other features with incubation time: 

























reported serogroup (4) and was also the dominant STEC described in our review accounting 
for 22 outbreaks out of 29. The O104 serogroup that caused the German outbreak accounted 
for 3 outbreaks, hence, the paucity of outbreaks caused by non-O157 serogroup may be 
responsible for the non-significant association between serogroup and incubation period. 
Despite this, all outbreaks associated with the O104 serogroup were clustered in one 
subgroup, which had the longest incubation period.  Mostly reporting serotype and toxin 
type, the outbreaks studied lacked more detailed microbial characterization. As routine STEC 
genome sequencing increases, testing of a wider range of pathogen factors for association 
with incubation period will be possible. The observed clustering of the O104 outbreaks 
within the same incubation time subgroup (Web Figure 3) (19–21,29), which outbreaks 
shared both a pathogen lineage and a transmission route through contaminated beansprouts 
supports the potential importance of these factors in affecting incubation period. 
The variability of incubation time distribution between outbreaks, and the large number of 
outbreaks with incubation times longer than those cited in reference materials (1,3) is 
striking. The mean incubation time across the seven outbreaks in subgroup 4 was longer than 
the standard ranges proposed for individual cases (1,3). Even acknowledging that three of 
these seven were from those outbreaks (19–21) within the large German O104 outbreak (14) 
with identifiable incubation times and one from a related O104 outbreak in France (29), this 
large cluster of outbreaks with longer than expected incubation times highlights the risks 
associated with restricting investigation to exposures occurring within expected incubation 
time distributions. A consequence is the need for outbreak investigators to consider a wide 
range of potential incubation times. The current work offers an evidence base of the scale of 
variation to inform future editions of reference materials. 
Although we have been able to summarize data across the published literature our study is 

























numerous outbreaks investigated and reported (5,11). The majority of STEC cases are either 
sporadic (30), and some are part of  continuous source outbreaks (31–34) where it is difficult 
to identify exposure time and therefore difficult to calculate incubation periods accurately. 
Many studies were excluded because, although they appear to have been gathered, these data 
were not reported in a way that allowed suitable data extraction. Standard approaches to 
reporting incubation period data in outbreak reports should be developed and would be useful 
for better understanding incubation periods. The same is no doubt true for other questions, 
including the effectiveness of control measures, where the natural experiments offered by 
outbreaks could contribute to evidence based practice if well reported and collated.  
One reporting feature of importance to incubation time is the case definition used. Where 
data for both were available we observed a period of four to seven days between onset of 
diarrhoea and onset of HUS, similar to that  reported by Razzaqq et al (35). In our review, 
most of the case definitions used by the authors included diarrhoea or bloody diarrhoea 
without HUS, while a few included all three clinical outcomes. We observed that studies 
reporting all clinical outcomes including HUS reported longer mean incubation period that 
other studies; however, we did not identify a significant association between HUS and the 
length of incubation period as also reported by Werber et al (22). We suspect that some of the 
heterogeneity we observed in the incubation period distribution across outbreaks may be 
explained by the differences in the case definitions. Reporting with more specific case 
definitions and even separation of results across cases based on different symptoms is thus 
one example of a feature of standard reporting that could promote better evidence synthesis. 
Even with detailed and standardized reporting of outbreaks there are limitations to using the 
published literature to study factors associated with incubation time. For these questions, 
individual patient data allowing analysis of host factors such as pre-morbidity, ongoing 

























transmission and pathogen characteristics. This raises questions on how best to capture, store, 
and make accessible data from individual outbreaks in a way that will allow joint analysis 
and align with the increasing trend toward individual patient data meta-analysis in the 
synthesis of randomised controlled trial evidence. 
The studies included in our review were predominantly outbreak reports where incubation 
period was not the main goal of investigation and the population being studied were cases 
being investigated as part of the outbreak. Therefore, there is very little possibility of 
encountering publication bias or selection bias due to the reported incubation period. 
Furthermore, we found no evidence of small-study effect. Although protecting against 
publication bias this lack of focus on sharing information on incubation period no doubt 
contributed to the exclusion of studies, with the majority of studies we identified not meeting 
the quality assessment criteria for reporting of incubation period.  Extracting individual data 
involved the use of an online data extraction tool and a manual process of selecting each data 
point which is open to human error and could alter the reported incubation period, but these 
errors are likely to be small. Results are therefore not likely to be substantially biased, 
although based on a restricted number of studies reporting usable data. 
In conclusion, our study confirmed that the incubation period varied across outbreaks 
identifying several subgroups some of which had incubation periods far longer than expected 
based on standard estimates. We identified age and attack rate as factors that may influence 
the distribution of incubation period. However, there was insufficient information to explain 
the relationship between these factors and incubation period or to study the impact of many 
individual patient level factors on incubation period. Our work highlights both the 
opportunities afforded for information synthesis across outbreaks to support evidence-based 
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Web Figure 1. Collated Epidemic Curves of Included Studies  
Web Figure 2. Dendrogram Showing Dissimilarity Matrix and Associated Subgroups 
Web Figure 3. Forest Plot Showing Mean Incubation Period and Subgroup Summary Mean 
 
 


























































Table 1. Modified PICO Element in the Systematic Review of Studies Between 1984 and 
2012 
PICO Elements Components 
Population studies/Participants Cases of STEC in a laboratory confirmed point 
source exposure outbreak or continuous source 
outbreak where date of exposure and onset is known 
for each case. 
 Individual case laboratory confirmation was not 
required within each outbreak where cases met a 
clinical and epidemiological case definition. 
Infectious Agent Shiga-toxin producing Escherichia coli 
Comparator Host factors and outbreak characteristics: food 
vehicle and level of contamination/dose 
 Clinical characteristics such as HUS and bloody 
diarrhoea 
 Microbiological characteristics such as serotype ad 
toxin type 
Outcome Time from exposure to onset of clinical illness as 
described or defined by the reporting authors 
including diarrhoea, bloody diarrhoea, abdominal 
pain, vomiting, HUS 
Abbreviations: PICO: Population studies, Infectious Agent, Comparator and Outcome; 



























Table 2. Characteristics of Included Outbreaks in the Systematic Review of STEC Between 
1984 and 2012 
Variables Number of outbreaks Proportion 
Total number of outbreaks 29  
Year of study   
Before year 2000 16 55.2 
2000 and later 13 44.8 
Study design   
Case control study 9 31.0 
Case study 1 3.4 
Cohort study 14 48.3 
Descriptive 5 17.2 
Age group   
Children  15 51.7 
Adults 13 44.8 
Mixed 0 0.0 
Unknown 1 3.4 
Region of study   
Europe 16 55.2 
North America 8 27.6 
Asia 5 17.2 
Serotype   
O157 22 75.9 

























O127 1 3.4 
O145 & O26 1 3.4 
O103 1 3.4 
Toxin type   
VT1 & VT2 9 31.0 
VT2 alone  8 27.6 
VT1 alone 3 10.3 
Unknown  9 31.0 
Clinical outcome   
Bloody diarrhoea 9 31.0 
HUS alone 9 31.0 
Both 10 34.5 
Unknown 1 3.4 
Foodborne transmission 20 69.0 
Private party 8 40.0 
Nursing homes 4 20.0 
School 4 20.0 
Community 1 5.0 
Farm visit 1 5.0 
Restaurant 2 10.0 
Non-foodborne transmission 9 31.0 
Farm visit 4 44.4 
Laboratory acquired 1 11.1 

























Surface water 1 11.1 
Swimming pool 1 11.1 
Food vehicle   
Vegetables 7 35.0 
Red meat 4 20.0 
Dairy 3 15.0 
Poultry 2 10.0 
Others 2 10.0 
Unknown 2 10.0 
Abbreviations: STEC: Shiga-toxin producing Escherichia coli; VT: Vero-toxin; HUS: 




























Table 3. Generalised Linear Regression Model Identifying Factors Associated with 
Incubation Period in the Systematic Review of Studies Between 1984 and 2012. 
Variables Univariate model 
(difference in days) 
P value Multivariable model 
(difference in days) 
P value 
Age  0.01  0.06 
Adult Reference    
Children -2.70  -2.10  
Attack rate -0.03 0.03 -0.03 0.06 
Setting     
Other Reference    
Farm 1.40 0.40   
Nursing home 3.20 0.10   
Outdoor 1.10 0.60   
Private party 3.10 0.10   
School -0.60 0.70   
Restaurant 1.50 0.40   
Mode of transmission  0.50   
Foodborne Reference    
Non-foodborne -0.60    
Serotype  0.30   
Non O157 Reference    
O157 -1.20    
Toxin type     

























VT2 1.50 0.30   
VT1 & VT2 1.50 0.30   
Bloody diarrhoea  0.90   
No Reference    
Yes -0.10    
HUS  0.70   
No Reference    
Yes 0.30    
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